ArticlePediatric health, medicine and therapeutics2026
Maternal Folic Acid Supplementation and Neural Tube Defects in Northeast Iran: Insights for Developing Countries.
Article in Pediatric health, medicine and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neural tube defects (NTDs) are among the most common severe congenital malformations, caused by incomplete closure of the neural tube in the third and fourth weeks after conception. This study aimed to investigate potential maternal and environmental risk factors associated with NTDs in newborns under the coverage of Mashhad University of Medical Sciences. Methods: A descriptive case-control study was conducted using the Integrated Health Information System. All NTDs newborns (n=126) were case identified while three times of the number of mothers of healthy newborns (n=378) were picked as controls. Maternal and neonatal factors like folic acid supplementation, maternal age, BMI, parity, smoking, passive smoking, consanguinity, and neonatal sex were collected and processed with SPSS 27 software. Chi-square, Fisher's exact test, and logistic regression were employed. Results: Among mothers of NTD-affected newborns, 20.6% reported folic acid supplementation versus 31.5% in controls (P=0.02). The gender of the newborn, mother's age, BMI, number of children, education level, kinship, history of having affected child, and history of stillbirth showed no significant difference between cases and controls. Logistic regression results showed that not taking folic acid increased the likelihood of NTDs by more than two times (OR=2.11, P=0.006). Conclusion: Maternal folic acid supplementation was significantly associated with reduced risk of NTDs. No significant relationship was found with the other factors studied.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.